Amicus Therapeutics
FOLD
FOLD
200 hedge funds and large institutions have $3.53B invested in Amicus Therapeutics in 2018 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 67 increasing their positions, 65 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.46% less ownership
Funds ownership: 120.54% → 120.08% (-0.46%)
3% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 33
1% less funds holding
Funds holding: 203 → 200 (-3)
Holders
200
Holding in Top 10
11
Calls
$74.3M
Puts
$13.8M
Top Buyers
| 1 | +$65.1M | |
| 2 | +$18.8M | |
| 3 | +$16.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$15.1M |
| 5 |
BlackRock
New York
|
+$14.5M |
Top Sellers
| 1 | -$34M | |
| 2 | -$21.8M | |
| 3 | -$13.1M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$11.3M |
| 5 |
D.E. Shaw & Co
New York
|
-$10.9M |